全文获取类型
收费全文 | 778篇 |
免费 | 66篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 45篇 |
妇产科学 | 16篇 |
基础医学 | 147篇 |
口腔科学 | 12篇 |
临床医学 | 72篇 |
内科学 | 173篇 |
皮肤病学 | 18篇 |
神经病学 | 80篇 |
特种医学 | 23篇 |
外科学 | 101篇 |
综合类 | 7篇 |
预防医学 | 48篇 |
眼科学 | 9篇 |
药学 | 26篇 |
中国医学 | 1篇 |
肿瘤学 | 59篇 |
出版年
2023年 | 12篇 |
2022年 | 15篇 |
2021年 | 26篇 |
2020年 | 17篇 |
2019年 | 13篇 |
2018年 | 16篇 |
2017年 | 13篇 |
2016年 | 19篇 |
2015年 | 23篇 |
2014年 | 34篇 |
2013年 | 34篇 |
2012年 | 46篇 |
2011年 | 41篇 |
2010年 | 32篇 |
2009年 | 24篇 |
2008年 | 34篇 |
2007年 | 39篇 |
2006年 | 45篇 |
2005年 | 32篇 |
2004年 | 32篇 |
2003年 | 39篇 |
2002年 | 36篇 |
2001年 | 26篇 |
2000年 | 25篇 |
1999年 | 24篇 |
1998年 | 13篇 |
1997年 | 14篇 |
1996年 | 7篇 |
1995年 | 9篇 |
1992年 | 11篇 |
1991年 | 8篇 |
1990年 | 8篇 |
1989年 | 7篇 |
1988年 | 7篇 |
1987年 | 2篇 |
1986年 | 2篇 |
1985年 | 8篇 |
1984年 | 8篇 |
1983年 | 6篇 |
1981年 | 3篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1974年 | 4篇 |
1972年 | 2篇 |
1971年 | 3篇 |
1970年 | 3篇 |
1969年 | 4篇 |
1958年 | 1篇 |
1912年 | 2篇 |
排序方式: 共有846条查询结果,搜索用时 31 毫秒
31.
32.
Luise Roehrich Simon Suendermann MD Isabell Anna Just MD Jan Knierim MD Johanna Mulzer MD Marcus Mueller Jaime-Juergen Eulert-Grehn MD Manfred Hummel MD Christoph Starck MD Evgenij Potapov MD Christoph Knosalla MD Volkmar Falk MD Felix Schoenrath MD 《Pacing and clinical electrophysiology : PACE》2020,43(10):1078-1085
33.
Flora Peyvandi Gili Kenet Isabell Pekrul Rajiv K. Pruthi Peter Ramge Michael Spannagl 《Journal of thrombosis and haemostasis》2020,18(6):1242-1255
The advent of extended half‐life (EHL) recombinant clotting factors and innovative non‐factor replacement therapeutics, such as emicizumab, offers several advantages over existing products for the prophylactic treatment of people living with hemophilia (PwH). These include low annual bleeding rates with less frequent dosing, higher trough plasma concentrations, and a more convenient route of administration. However, increasing use of these therapies poses challenges to clinicians and coagulation laboratories due to the lack of standardized assays for monitoring of hemostatic parameters, and the potential for misinterpretation of test results, which may jeopardize patient safety. Definitive diagnosis of hemophilia and treatment monitoring is reliant on demonstrating factor VIII (FVIII; hemophilia A) or factor IX (FIX; hemophilia B) deficiency using a functional coagulation assay. The most frequently used assays are based on activated partial thromboplastin time, using a one‐stage or two‐stage process. While one‐stage and chromogenic assays have performed well with human‐derived FVIII and FIX and full‐length recombinant products, EHL recombinant factors are heterogeneous in structure and mode of action and therefore show wide variation in activity levels between different one‐stage assays, and between one‐stage and chromogenic assays. In the context of the recommended stepwise approach for laboratory diagnosis of hemophilia, we examine the diagnostic challenges associated with the use of EHL factors and novel non‐factor therapeutics and consider the optimal diagnostic approach in PwH who are receiving these treatments. Ultimately, accurate diagnostic solutions are a prerequisite for personalized therapy to minimize treatment burden and improve quality of life in PwH. 相似文献
34.
35.
Myrna J. V. Brandt Cora H. Nijboer Isabell Nessel Tatenda R. Mutshiya Adina T. Michael-Titus Danielle S. Counotte Lidewij Schipper Niek E. van der Aa Manon J. N. L. Benders Caroline G. M. de Theije 《Nutrients》2022,14(1)
Perinatal hypoxia-ischemia (HI) is a major cause of neonatal brain injury, leading to long-term neurological impairments. Medical nutrition can be rapidly implemented in the clinic, making it a viable intervention to improve neurodevelopment after injury. The omega-3 (n-3) fatty acids docosahexaenoic acid (DHA, 22:6n-3) and eicosapentaenoic acid (EPA, 20:5n-3), uridine monophosphate (UMP) and choline have previously been shown in rodents to synergistically enhance brain phospholipids, synaptic components and cognitive performance. The objective of this study was to test the efficacy of an experimental diet containing DHA, EPA, UMP, choline, iodide, zinc, and vitamin B12 in a mouse model of perinatal HI. Male and female C57Bl/6 mice received the experimental diet or an isocaloric control diet from birth. Hypoxic ischemic encephalopathy was induced on postnatal day 9 by ligation of the right common carotid artery and systemic hypoxia. To assess the effects of the experimental diet on long-term motor and cognitive outcome, mice were subjected to a behavioral test battery. Lesion size, neuroinflammation, brain fatty acids and phospholipids were analyzed at 15 weeks after HI. The experimental diet reduced lesion size and neuroinflammation specifically in males. In both sexes, brain n-3 fatty acids were increased after receiving the experimental diet. The experimental diet also improved novel object recognition, but no significant effects on motor performance were observed. Current data indicates that early life nutritional supplementation with a combination of DHA, EPA, UMP, choline, iodide, zinc, and vitamin B12 may provide neuroprotection after perinatal HI. 相似文献
36.
37.
38.
39.
40.